FAST Filing
4Filing Date: Mar 6, 2026

FASTENAL CO (FAST) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0001246432-26-000006open_in_new
Total Value$2.23M
Trades3
Insiders1

Transaction Details

Wisecup Reyne K
Director·Direct
Exercise · Acquire
Common Stock
Shares+36.92K
Price$13.00
Total Value$480.0K
Shares Owned After76.92K
Transaction DateMar 5, 2026
Wisecup Reyne K
Director·Direct
Sell · Dispose
Common Stock
Shares-36.92K
Price$47.34
Total Value$1.75M
Shares Owned After40.00K
Transaction DateMar 5, 2026
Wisecup Reyne K
Director·Direct
Exercise · Dispose
Employee Stock Option (Right to Buy)Derivative
Shares-36.92K
Price$0.00
Total Value$0
Shares Owned After0
Transaction DateMar 5, 2026
ExpiresDec 31, 2028
Footnotes ▸

The option was previously reported in a filing dated 1/3/2019 as covering 11,538 securities at a strike price of $52 and the amounts were adjusted to reflect a 2-for-1 stock splits on 5/22/2019 and 5/21/2025. | The option was previously reported in a filing dated 1/3/2019 as covering 11,538 securities at a strike price of $52 and the amounts were adjusted to reflect a 2-for-1 stock splits on 5/22/2019 and 5/21/2025. | The option will fully vest and become exercisable over a period of five years, with 40% vesting and becoming exercisable two years following the date of grant and the remainder vesting and becoming exercisable proportionately (20%) each year thereafter. | The option was previously reported in a filing dated 1/3/2019 as covering 11,538 securities at a strike price of $52 and the amounts were adjusted to reflect a 2-for-1 stock splits on 5/22/2019 and 5/21/2025.

Post-Transaction Holdings

Wisecup Reyne K
SecuritySharesChange
Common Stock76.92K-
Employee Stock Option (Right to Buy)0-36.92K (-100.00%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-03-05 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: FASTENAL CO (FAST) CIK: 0000815556 --- Reporting Owner --- Name: Wisecup Reyne K CIK: 0001246432 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-03-05 | Code: M (Exercise of derivative) Shares: +36,920 | Price: $13.00 Total Value: $479,960.00 Shares Owned After: 76,920 | Ownership: D (Direct) [Transaction #2] Security: Common Stock Date: 2026-03-05 | Code: S (Open market sale) Shares: -36,920 | Price: $47.34 Total Value: $1,747,922.02 Shares Owned After: 40,000 | Ownership: D (Direct) --- Derivative Transactions --- [Transaction #1] Security: Employee Stock Option (Right to Buy) Date: 2026-03-05 | Code: M (Exercise of derivative) Shares: -36,920 | Price: $0.00 Exercisable: N/A | Expires: 2028-12-31 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F1] The option was previously reported in a filing dated 1/3/2019 as covering 11,538 securities at a strike price of $52 and the amounts were adjusted to reflect a 2-for-1 stock splits on 5/22/2019 and 5/21/2025. [F1] The option was previously reported in a filing dated 1/3/2019 as covering 11,538 securities at a strike price of $52 and the amounts were adjusted to reflect a 2-for-1 stock splits on 5/22/2019 and 5/21/2025. [F2] The option will fully vest and become exercisable over a period of five years, with 40% vesting and becoming exercisable two years following the date of grant and the remainder vesting and becoming exercisable proportionately (20%) each year thereafter. [F1] The option was previously reported in a filing dated 1/3/2019 as covering 11,538 securities at a strike price of $52 and the amounts were adjusted to reflect a 2-for-1 stock splits on 5/22/2019 and 5/21/2025. --- Footnotes (Complete Index) --- F1: The option was previously reported in a filing dated 1/3/2019 as covering 11,538 securities at a strike price of $52 and the amounts were adjusted to reflect a 2-for-1 stock splits on 5/22/2019 and 5/21/2025. F2: The option will fully vest and become exercisable over a period of five years, with 40% vesting and becoming exercisable two years following the date of grant and the remainder vesting and becoming exercisable proportionately (20%) each year thereafter. --- Signature --- /s/ /s/ John J. Milek, Attorney-in-Fact (2026-03-06)

keid analysis is for reference only and does not constitute investment advice.